FDA Adverse Event Injury Summary report: N

XACT CAROTID STENT SYSTEM

MDR report key: 1133162 · Received August 22, 2008

Report

Report Number
9616695-2008-00128
Event Type
Injury
Date Received
August 22, 2008
Date of Event
July 28, 2008
Report Date
August 1, 2008
Manufacturer
ABBOTT VASCULAR GALWAY
Product Code
NIM
PMA / PMN Number
P040038
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE STENT REMAINS IN THE PT. THE LOT NUMBER WAS PROVIDED. STROKE IS A KNOWN POTENTIAL ADVERSE EFFECT ASSOCIATED WITH THE USE OF THE DEVICE AS LISTED IN THE INSTRUCTIONS FOR USE. THERE WAS NO DEVICE MALFUNCTION REPORTED. A REVIEW OF THE FINISHED DEVICE LOT HISTORY RECORD DID NOT REVEAL ANY NON-CONFORMITIES WHICH COULD HAVE CONTRIBUTED TO THIS COMPLAINT.

Description of Event or Problem · 1

DEVICE MALFUNCTION: NONE. SYMPTOMS/AE: STROKE. TIME OF AE: DURING THE PROCEDURE. IT WAS REPORTED THAT DURING A LEFT INTERNAL CAROTID ARTERY STENTING PROCEDURE, AFTER THE PLACEMENT OF THE STENT, THE PT HAD RIGHT UPPER EXTREMITY WEAKNESS AND MILD EXPRESSIVE APHASIA, DIAGNOSED AS A STROKE. NEUROLOGY WAS CALLED TO ASSESS SUBJECT IMMEDIATELY AFTER PROCEDURE. A CT SCAN WAS DONE SHOWING NO ACUTE INTRACRANIAL PATHOLOGY.; THE PT WAS SHOWING SOME IMPROVEMENT ONCE OUT OF THE CATHETER LAB. ONE DAY POSTPROCEDURE, AN MRI WAS DONE SHOWING PATCHY REGIONS OF ACUTE NONHEMORRHAGIC CORTICAL AND SUBCORTICAL INFARCTION OF THE LEFT CEREBRAL HEMISPHERE. DURING HOSPITALIZATION, THE PT WAS SEEN BY PHYSICAL, OCCUPATIONAL AND SPEECH THERAPY. EIGHT DAYS POSTPROCEDURE, STATUS SLIGHTLY IMPROVED, THE PT WAS DISCHARGED TO REHABILITATION FACILITY. ALTHOUGH REQUESTED, THERE IS NO ADDITIONAL INFO AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XACT CAROTID STENT SYSTEM NIM ABBOTT VASCULAR GALWAY NA 393109

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| S EMBOSHIELD EMBOLIC PROTECTION DEVICE| BIVALIRUDIN